Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

The molecular genetics of Philadelphia chromosome-positive leukemias.

Kurzrock R, Gutterman JU, Talpaz M.

N Engl J Med. 1988 Oct 13;319(15):990-8. Review. No abstract available.

PMID:
3047582
2.

[Cytogenetics of Philadelphia-chromosome-positive leukemias].

Carbonell F, Benítez J, Prieto F.

Sangre (Barc). 1984;29(4-B):535-47. Review. Spanish. No abstract available.

PMID:
6393381
3.

Similar molecular alterations occur in related leukemias with and without the Philadelphia chromosome.

Wiedemann LM, Karhi K, Chan LC.

Haematol Blood Transfus. 1987;31:149-52. No abstract available.

PMID:
3127279
4.

Rearrangement of bcr and c-abl sequences in Ph-positive acute leukemias and Ph-negative CML--an update.

Bartram CR.

Haematol Blood Transfus. 1987;31:160-2. No abstract available.

PMID:
3481751
5.

[Oncogenes and malignant hemopathies].

Pogliani EM, Bregani ER, Corneo G.

Recenti Prog Med. 1989 Oct;80(10):526-30. Review. Italian.

PMID:
2690219
6.

Chromosomal abnormalities in leukemia and lymphoma: clinical and biological significance.

Le Beau MM, Rowley JD.

Adv Hum Genet. 1986;15:1-54. Review. No abstract available.

PMID:
3513482
7.

The Philadelphia chromosome: from cytogenetics to oncogenes.

Goldman JM.

Br J Haematol. 1987 Aug;66(4):435-6. Review. No abstract available.

PMID:
3311122
8.

Breakpoint distribution in variant Philadelphia translocations in chronic myeloid leukemia.

De Braekeleer M.

Cancer Genet Cytogenet. 1986 Oct;23(2):167-70. No abstract available.

PMID:
3463405
9.

Application of cytogenetics in neoplastic diseases.

Sandberg AA.

Crit Rev Clin Lab Sci. 1985;22(3):219-74. Review.

PMID:
3899509
10.

Expression of c-abl in Philadelphia-positive acute myelogenous leukemia.

Kurzrock R, Shtalrid M, Talpaz M, Kloetzer WS, Gutterman JU.

Blood. 1987 Nov;70(5):1584-8. Review.

11.

The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy.

Van Etten RA.

Cancer Treat Res. 1993;64:295-325. Review. No abstract available.

PMID:
8095796
12.

t(4;21) (p16;q22) in blastic crisis of a chronic myeloid leukemia with variant Philadelphia translocation.

Donti E, Tabilio A, Rosetti A, Carotti A, Bordoni S, Falzetti F, Venti Donti G.

Leuk Res. 1986;10(12):1487-91.

PMID:
3467145
13.
14.

Localization of c-Ha-ras-1 oncogene in the t(7p-;11p+) abnormality of two cases with myeloid leukemia.

Mise K, Abe S, Sato Y, Miura Y, Sasaki M.

Cancer Genet Cytogenet. 1987 Dec;29(2):191-9.

PMID:
3315181
15.

Rearrangement of the c-abl and bcr genes in Ph-negative CML and Ph-positive acute leukemias.

Bartram CR.

Leukemia. 1988 Jan;2(1):63-4. No abstract available.

PMID:
3422329
16.

Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints.

Croce CM, Huebner K, Isobe M, Fainstain E, Lifshitz B, Shtivelman E, Canaani E.

Proc Natl Acad Sci U S A. 1987 Oct;84(20):7174-8.

17.

Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.

Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON.

Science. 1987 Jan 2;235(4784):85-8.

PMID:
3541203
18.

Genomic diversity of Philadelphia-positive chronic myelogenous leukemia.

Verma RS, Macera MJ.

Leuk Res. 1987;11(9):833-42. Review.

PMID:
3312828
19.

Regulation of the proto-oncogenes c-sis, c-fos, c-myc and c-myb in acute myeloid leukemias.

Strassburg CP, Neubauer V, Poliwoda H, Benter T.

Neoplasma. 1992;39(6):343-7.

PMID:
1491723
20.

C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.

Romero P, Blick M, Talpaz M, Murphy E, Hester J, Gutterman J.

Blood. 1986 Mar;67(3):839-41.

Supplemental Content

Support Center